Esperance Pharmaceuticals' Series A - II Round

Esperance Pharmaceuticals raised a round of funding on February 06, 2009.

Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.…

Articles about Esperance Pharmaceuticals' Series A - II Round: